US: FSIS to exclude vaccine strains from Salmonella performance categorization

United States

Regulation & Compliances

Market & Price Trends

Published Mar 7, 2024

Tridge summary

The Food Safety and Inspection Service (FSIS) has revised its raw poultry Salmonella performance standards calculation to exclude commercial vaccine subtypes. This decision comes after data from 11 pilot projects revealed that vaccine strains can sometimes be found in raw poultry products, even when correctly used, which would previously count as a positive result. The policy change aims to promote the use of vaccination as a Salmonella control strategy.

Disclaimer: The above summary was generated by a state-of-the-art LLM model and is intended for informational purposes only. It is recommended that readers refer to the original article for more context.

Original content

The decision was made after collecting data from 11 pilot projects that tested different strategies for Salmonella control in poultry products. In 2021, FSIS made the announcement that as part of its ongoing efforts to reduce foodborne illnesses caused by Salmonella, it would invite poultry processors to submit proposals for Salmonella control pilot projects. FSIS would then analyze the data to determine whether it supports changes to existing FSIS Salmonella control strategies. Since March 2023, project proposals from nine different establishments, including Pilgrim’s Pride, Miller Poultry, Foster Farms, and Bell & Evans, were approved by FSIS. FSIS examined Salmonella detection and serotype data from flocks vaccinated with a modified live Salmonella vaccine at pre- and post-intervention points in the participating establishments. The data indicated that vaccine strains can occasionally be found in raw poultry products even when the vaccine is used as directed on the label. FSIS’ ...

Source: Meat+Poultry